Timeline

Olivier Leclercq
Research Engineer
27 Sep 2022
project

ANR Texleish: Targeting host-parasite interactions through the inhibition of excreted leishmania casein kinase 1

Read more
22 Sep 2022
project

Pasteur-Weizmann project: Role of kinases in vesicle-mediated regulation of host-pathogen interactions: Focus on Leishmania donovani and Plasmodium falciparum.

Read more
20 Sep 2022
project

Campus France procope: CASEIN KINASE 1, A KEY REGULATOR OF TUMORIGENESIS AND HOST-PATHOGEN INTERACTIONS

Read more
08 Feb 2022
team

Signalling and host-parasite interactions

Read more
15 Jan 2021
publication

In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition.

Read more
01 May 2016
publication

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Read more
14 Sep 2015
project

PTR 392 – Systems-wide analysis of Leishmania virulence

Read more
07 Sep 2015
project

FP7 Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug)

Read more
07 Sep 2015
project

ANR TransLeish – Discovery of druggable protein kinases in the protozoan parasite Leishmania donovani using hit compounds identified by phenotypic screening

Read more
11 May 2015
team

Molecular Parasitology and Signaling

Read more
01 Sep 2014
publication

Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability.

Read more
01 Jul 2014
publication

Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses.

Read more
01 Jan 2014
publication

Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Read more
16 May 2013
publication

Enrichment of Leishmania donovani ATP-binding proteins using a staurosporine capture compound.

Read more
09 Aug 2012
publication

The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms.

Read more
26 Mar 2011
publication

Adaptation of a 2D in-gel kinase assay to trace phosphotransferase activities in the human pathogen Leishmania donovani.

Read more
29 Jun 2010
publication

Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Read more
23 Jan 2008
publication

Ectopic expression of AID in a non-B cell line triggers A:T and G:C point mutations in non-replicating episomal vectors.

Read more